A novel pathway for receptor-mediated post-translational activation of inducible nitric oxide synthase.
about
Plasma kallikrein-kinin system and diabetic retinopathyThe kallikrein-kinin system and oxidative stressAmelioration of cardiac function and activation of anti-inflammatory vasoactive peptides expression in the rat myocardium by low level laser therapy.Angiotensin II inhibits insulin-stimulated GLUT4 translocation and Akt activation through tyrosine nitration-dependent mechanisms.Differential regulation of inducible and endothelial nitric oxide synthase by kinin B1 and B2 receptorsBeta-arrestin 2 is required for B1 receptor-dependent post-translational activation of inducible nitric oxide synthase.Downregulation of kinin B1 receptor function by B2 receptor heterodimerization and signaling.Cross-talk between carboxypeptidase M and the kinin B1 receptor mediates a new mode of G protein-coupled receptor signalingComparative proteomics of cerebrospinal fluid reveals a predictive model for differential diagnosis of pneumococcal, meningococcal, and enteroviral meningitis, and novel putative therapeutic targets.Characterization of dual agonists for kinin B1 and B2 receptors and their biased activation of B2 receptorsCarboxypeptidase M augments kinin B1 receptor signaling by conformational crosstalk and enhances endothelial nitric oxide outputEndothelial nitric-oxide synthase activation generates an inducible nitric-oxide synthase-like output of nitric oxide in inflamed endothelium.Kininase 1 As a Preclinical Therapeutic Target for Kinin B1 Receptor in Insulin Resistance.A primary role for kinin B1 receptor in inflammation, organ damage, and lethal thrombosis in a rat model of septic shock in diabetes.Interplay between the kinin B1 receptor and inducible nitric oxide synthase in insulin resistance.Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.Annonaceae: Breaking the Wall of Inflammation.Implication of the Kallikrein-Kinin system in neurological disorders: Quest for potential biomarkers and mechanisms.
P2860
Q26859982-39B9C979-05D9-4891-B09D-0CC2EE06AFBAQ27000456-6495D2CB-5445-461B-AE62-23C4808960B1Q31171637-F3C0C73C-249C-4B6E-8E80-8ABD3389A1DBQ33552248-42B5AF3B-1305-4DB8-9F49-A24D865BBDD2Q33695494-543E1937-7DC4-41C0-81F0-32E10DF8EDA4Q33919473-176A82CD-EA57-429B-B741-7B9112317531Q34617439-520389A4-60C6-40AA-AB9F-06A4568EED38Q34998057-577F6CEB-18B7-4353-A7A7-B2DCAA0FBD27Q35651817-F7846180-D158-4D08-8091-2B9BAE35D0FDQ35996074-C0276676-9E8F-4E47-8EB1-67268A8DB6EDQ36593321-B72FC68F-51E4-4C32-8D57-1DA2C3159EBBQ36596268-8EA32DB7-A83B-41B1-A905-3430A8E24F8CQ38616792-712E0967-7B7E-48F3-99D4-37B5B5FE302CQ40493046-A31944EC-B167-471A-9C48-2DB77F1AF2C1Q41912702-4ABDB84C-4019-4D96-95CC-152213251293Q45072634-AE55A1FC-0ED0-4988-89B8-F652712B7C13Q46268493-4F4AD3CE-6203-4F03-830C-FF763BA358A8Q47720411-A2D4020E-3F2B-476E-A687-CCD01095A97F
P2860
A novel pathway for receptor-mediated post-translational activation of inducible nitric oxide synthase.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A novel pathway for receptor-m ...... ducible nitric oxide synthase.
@ast
A novel pathway for receptor-m ...... ducible nitric oxide synthase.
@en
type
label
A novel pathway for receptor-m ...... ducible nitric oxide synthase.
@ast
A novel pathway for receptor-m ...... ducible nitric oxide synthase.
@en
prefLabel
A novel pathway for receptor-m ...... ducible nitric oxide synthase.
@ast
A novel pathway for receptor-m ...... ducible nitric oxide synthase.
@en
P2093
P2860
P1476
A novel pathway for receptor-m ...... ducible nitric oxide synthase.
@en
P2093
Randal A Skidgel
Richard D Minshall
Svitlana Brovkovych
Viktor Brovkovych
Yongkang Zhang
P2860
P304
P356
10.1111/J.1582-4934.2009.00992.X
P577
2011-02-01T00:00:00Z